Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheumatoid Arthritis

Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis

NCT00420927 ·Status: COMPLETED ·Phase: PHASE4

Effects of Abatacept in Patients With Early Rheumatoid Arthritis

NCT02504268 ·Status: COMPLETED ·Phase: PHASE3

A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis

NCT01162421 ·Status: COMPLETED ·Phase: PHASE4

A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate

NCT00048568 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid Arthritis

NCT00448383 ·Status: COMPLETED ·Phase: PHASE3

A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy

NCT01960855 ·Status: COMPLETED ·Phase: PHASE2

Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate

NCT00235859 ·Status: COMPLETED ·Phase: PHASE3

Assessment of Clinical Effectiveness and Safety of Adalimumab and High Dose Methotrexate in Routine Clinical Practice

NCT01736189 ·Status: COMPLETED

Abatacept With Methotrexate- Phase IIB

NCT00162266 ·Status: COMPLETED ·Phase: PHASE2

Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis

NCT00233558 ·Status: TERMINATED ·Phase: PHASE4

A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate

NCT02629159 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study Investigating the Efficacy and Safety of Upadacitinib (ABT-494) Given With Methotrexate (MTX) in Adults With Rheumatoid Arthritis Who Have Had an Inadequate Response to MTX Alone

NCT02066389 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

NCT02141997 ·Status: COMPLETED ·Phase: PHASE2

A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects.

NCT00141934 ·Status: COMPLETED ·Phase: PHASE2

A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate

NCT04909801 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

ACP-196 Versus Placebo in Subjects With Rheumatoid Arthritis on Background Methotrexate

NCT02387762 ·Status: COMPLETED ·Phase: PHASE2

A Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY)

NCT02706951 ·Status: COMPLETED ·Phase: PHASE3

Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA)

NCT01185301 ·Status: COMPLETED ·Phase: PHASE3

A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate

NCT00345748 ·Status: COMPLETED ·Phase: PHASE2

An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate

NCT01764997 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis

NCT01142726 ·Status: COMPLETED ·Phase: PHASE3

A Study in Patients With Rheumatoid Arthritis

NCT00966875 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis

NCT02557100 ·Status: COMPLETED ·Phase: PHASE4

Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis

NCT00298272 ·Status: TERMINATED ·Phase: PHASE2

Effect of Two Methotrexate in Sync With the First Adalimumab to Prevent the Immunisation Anti Ada in Spondyloarthritis

NCT04360785 ·Status: COMPLETED ·Phase: NA